Global Congress on Infectious Diseases & HIV/AIDS
  • Follow

Accepted Abstracts

To Assess the Prevalence of Drug Resistant Tuberculosis in Kasama District Between June 2016 and June 2018

Davies Kalunga Chisenga*
Kasama General Hopital, Zambia

Citation: Chisenga DK (2020) To Assess the Prevalence of Drug Resistant Tuberculosis in Kasama District Between  June 2016 and June 2018. SciTech Infectious Diseases 2020. Mauritius 

Received: November 07, 2019         Accepted: November 12, 2019         Published: November 12, 2019

Abstract

Introduction: Tuberculosis continues to be a major public health problem in Zambia estimated at 376/100,000 population and incidence rate of 427/100,000. The prevalence of MDR TB, in new patients is estimated at 1.8% and 2.3% in previously treated cases, based on 2001 drug resistant survey. A retrospective prevalence study was conducted to assess and understand the DR‐TB situation in Kasama district between June 2017 and June 2018.

Method: A cross-sectional retrospective prevalence study which employed self-weighted character 100% sampling method was used. All eligible 308 records at the 9 diagnostic Centers were included.

Results: The proportion of new TB cases that had resistance to first-line anti-tuberculosis was 10.7%, while primary resistance =8.3%.and secondary resistance 2.6%, Rifampicin resistant at 2.3. %, by gender 104/308 men and women 226/308 between 22 to 30years, further non-evaluation of treatment outcomes at 39.6%., cure rate   42.56%, The comorbidity was at 42.3%.

Conclusion: The proportion of new TB cases, primary, Rifampicin and previously treated cases resistant to first-line anti-tuberculosis, non-evaluation of treatment outcomes and comorbidity was significantly high, while the Cure rate was drastically low.

Keywords: Proportion. Drug resistant, Tuberculosis